AcknowledgementsThis investigation was supported by the French National Agency of Medicine and Health Products Safety (ANSM – Agence Nationale de Sécurité du Médicament et des produits de santé) and ID2Santé Bretagne.
Appendix A. Supplementary dataThe following is the supplementary data related to this Sirolimus article:
Help with DOCX filesOptionsDownload file (19 K)Transparency document
Help with ZIP filesOptionsDownload file (11373 K)
Allergenicity scaling; Allergenic foods; Public health importance; Risk management; Prioritization; Labelling
Classification of the paper
Food Safety; Food toxicology; Immunotoxicology; Hypersensitivity; Immunotoxicity; Risk assessment
prs.rt(\"abs_end\");
1. Introduction
There is a need to scale the relative allergenicity of foods and proteins and the hazards or risks arising from this allergenicity.![image]()
This includes proteins which pose a known risk to the public and novel proteins arising from biotechnology, modified species or new food sources. Prioritisation according to the public health impact of allergenic foods ensures that scarce resources are allocated in such a way that they address those allergens that matter most from a public health point of view. Both regulators and risk managers in general need to decide whether a food allergen is of such public health importance that it must be actively managed. Objective criteria would improve transparency and trust in the decision-making process and its conclusions.
Appendix A. Supplementary dataThe following is the supplementary data related to this Sirolimus article:
Help with DOCX filesOptionsDownload file (19 K)Transparency document
Help with ZIP filesOptionsDownload file (11373 K)
Allergenicity scaling; Allergenic foods; Public health importance; Risk management; Prioritization; Labelling
Classification of the paper
Food Safety; Food toxicology; Immunotoxicology; Hypersensitivity; Immunotoxicity; Risk assessment
prs.rt(\"abs_end\");
1. Introduction
There is a need to scale the relative allergenicity of foods and proteins and the hazards or risks arising from this allergenicity.
This includes proteins which pose a known risk to the public and novel proteins arising from biotechnology, modified species or new food sources. Prioritisation according to the public health impact of allergenic foods ensures that scarce resources are allocated in such a way that they address those allergens that matter most from a public health point of view. Both regulators and risk managers in general need to decide whether a food allergen is of such public health importance that it must be actively managed. Objective criteria would improve transparency and trust in the decision-making process and its conclusions.